The neuroendocrine immunology of rheumatoid arthritis

Adler, 1990, Regulated expression of the human corticotropin releasing hormone by cAMP, Molecular Cell Endocrinology, 70, 165, 10.1016/0303-7207(90)90156-3 Akira, 1990, Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF), FASEB Journal, 4, 2860, 10.1096/fasebj.4.11.2199284 Al-Damluji, 1985, Adrenergic and opiod control of ACTH secretion in man, Neuroscience Letters, 22, S406 Al-Damluji, 1990, Vasopressin mediates alpha-1-adrenergic stimulation of adrenocorticotrophin secretion, Endocrinology, 126, 1989, 10.1210/endo-126-4-1989 Antoni, 1986, Hypothalamic control of ACTH secretion advances since the discovery of CRH, Endocrine Reviews, 7, 351, 10.1210/edrv-7-4-351 Arbiser, 1988, Human corticotropin releasing hormone gene is located on the long arm of chromosome 8, Cytogenetics and Cell Genetics, 47, 113, 10.1159/000132525 Bacon, 1994, The significance of vascular inflammation in rheumatoid arthritis, Annals of Rheumatic Diseases, 53, 621, 10.1136/ard.53.10.621 Bertoglio, 1988, Differential effects of glucocorticosteroids on the proliferation of a murime helper and cytotoxic cell clone in response to IL-2 and IL-4, Journal of Immunology, 141, 1191, 10.4049/jimmunol.141.4.1191 Beyer, 1988, Regulation of mRNA of CRH in the paraventricular nucleus and other brain sites of the rat, Endocrinology, 123, 2117, 10.1210/endo-123-4-2117 Blatteis, 1994, Neuromodulation of fever: a possible role for substance P, Annals of the New York Academy of Science, 741, 162, 10.1111/j.1749-6632.1994.tb23097.x Boki, 1992, HLA class 2 sequence polymorphism and susceptibility to rheumatoid arthritis in Greeks, Arthritis and Rheumatism, 35, 749, 10.1002/art.1780350706 Boki, 1993, Examination of HLA DR4 as a severity marker for rheumatoid arthritis in Greek patients, Annals of Rheumatic Diseases, 52, 517, 10.1136/ard.52.7.517 Burns, 1989, A two step mechanism by which CRH releases hypothalamic β-endorphin: the role of vasopressin and G proteins, Endocrinology, 125, 1365, 10.1210/endo-125-3-1365 Calogero, 1992, Neurotransmitter-induced hypothalamicpituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivoand in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone, Neuroendocrinology, 55, 600, 10.1159/000126173 Carter, 1990, Purification, cloning, expression and biological activity of an interleukin-1 receptor antagonist, Nature, 344, 633, 10.1038/344633a0 Cash, 1992, Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone, Journal of Rheumatology, 19, 1692 Chikanza, 1991, New insights: Auto-immunity and connective tissue diseases, Central African Journal of Medicine, 37, 427 Chikanza, 1995, The hypothalamic-pituitary adrenal effects of non-steroidal anti-inflammatory drugs, Arthritis and Rheumatism, 38, 723, 10.1002/art.1780380529 Chikanza, 1991, Hypothalamic-pituitary mediated modulation of immune function: Prolactin is a neuroimmune peptide, British Journal of Rheumatology, 30, 203, 10.1093/rheumatology/30.3.203 Chikanza, 1993, The effects of hydrocortisone on in vitro lymphocyte proliferation and interleukin-2 and -4 production in corticosteroid sensitive and resistant subjects, European Journal of Clinical Investigations, 23, 845, 10.1111/j.1365-2362.1993.tb00740.x Chikanza, 1992, Abnormal neuroendocrine immune communications in rheumatoid arthritis, European Journal of Clinical Investigations, 22, 635, 10.1111/j.1365-2362.1992.tb01422.x Chikanza, 1993, TNF soluble receptors (TNF inhibitors) behave as acute phase proteins following major surgery in patients with rheumatoid arthritis, osteomyelitis and osteoarthritis, Clinical Experimental Immunology, 92, 19, 10.1111/j.1365-2249.1993.tb05941.x Chikanza, 1995, Arginine vasopressin secretion in rheumatoid arthritis: pathophysiological implications, Arthritis and Rheumatism, 38, S216 Chikanza, 1995, Dysregulated interleukin-1 receptor antagonist protein production in rheumatoid arthritis; pathogenetic implications, Arhtritis and Rheumatism, 38, 642, 10.1002/art.1780380511 Chikanza, 1992, Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis, Arthritis and Rheumatism, 35, 1281, 10.1002/art.1780351107 Chikanza, 1993, HLA DRB allelic variation and rheumatoid arthritis in Zimbabwe, British Journal of Rheumatology, 31, 8 Chikanza, 1993, Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications, British Journal of Rheumatology, 32, 445, 10.1093/rheumatology/32.6.445 Chowdrey, 1990, Substance P stimulates AVP and inhibits ACTH release in vivo in the rat, Neuroendocrinology, 52, 90, 10.1159/000125544 Colville-Nash, 1992, Angiogenesis and rheumatoid arthritis: pathogenetic and therapeutic implicaions, Annals of Rheumatic Diseases, 50, 124 Costa, 1993, Nitric oxide modulates the release of corticotropin releasing hormone from the rat hypothalamus, Brain Research, 605, 187, 10.1016/0006-8993(93)91739-F Crofford, 1993, Corticotropin-releasing hormone in synovial fluids and tissues of patiebts with rheumatoid arthritis and osteoarthritis, Journal of Immunology, 151, 1587, 10.4049/jimmunol.151.3.1587 Cutolo, 1991, Sex hormones, HLA and rheumatoid arthritis, Clinical Experimental Rheumatology, 9, 641 Cutolo, 1995, The role of androgens in the pathophysiology of rheumatoid arthritis, Fundamental and Clinical Immunology, 3, 9 Daynes, 1989, Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors IL-2 and IL-4, European Journal of Immunology, 19, 2319, 10.1002/eji.1830191221 Dougados, 1988, Bromocriptine and cyclosporin A combination therapy in rheumatoid arthritis, Arthritis and Rheumatism, 31, 1333, 10.1002/art.1780311022 Edmonds, 1993, An imaginative approach to synovitis—the role of hypoxic reperfusion damage in arthritis, Journal of Rheumatology, 20, 26 Ferrari, 1989, Cabergoline: long-acting oral treatment of hyperprolactinemic disorders, Journal of Clinical Endocrinology and Metabolism, 68, 1201, 10.1210/jcem-68-6-1201 Firestein, 1994, Rheumatoid synovitis and pannus, 12.1 Firestein, 1990, How important are T cells in chronic rheumatoid synovitis, Arthritis and Rheumatism, 33, 768, 10.1002/art.1780330602 Fischer, 1990, Interleukin-1 receptor antagonist circulates in experimental inflammation and human disease, Blood, 79, 2192 Fitzpatrick, 1992, Glucorticoids in the non-obese (NOD) mouse: basal serum levels, effect of endocrine manipulation and immobilization stress, Life Science, 50, 1063, 10.1016/0024-3205(92)90102-U Folkman, 1987, Angiostatic steroids: method of discovery and mechanism of action, Annals of Surgery, 206, 374, 10.1097/00000658-198709000-00016 J, 1990, Effects of repetitive administration of CRH combined with lysine vasopressin on plasma ACTH and cortisol in secondary adrenal insufficiency, Journal of Clinical Endocrinology and Metabolism, 1, 1624 Ganapathi, 1991, Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells, Journal of Immunology, 147, 1261, 10.4049/jimmunol.147.4.1261 Garcia, 1992, β-endorphin inhibits IL-2 release and expression of IL-2 receptor in conA stimulated splenic lymphocytes, Lymphocyte Cytokine Research, 11, 339 Gerencer, 1982, An association between serum testosterone level and HLA phenotype, Immunology Letters, 4, 155, 10.1016/0165-2478(82)90028-1 German, 1993, Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on Th1 but not Th2 cells, European Journal of Immunology, 23, 1762, 10.1002/eji.1830230805 Gillies, 1982, Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin, Nature, 299, 355, 10.1038/299355a0 Goland, 1991, Adrenocorticotropin and cortisol responses to vasopressin during pregnancy, Journal of Clinical Endocrinology and Metabolism, 3, 257, 10.1210/jcem-73-2-257 Gregersen, 1987, The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis and Rheumatism, 30, 1205, 10.1002/art.1780301102 Guillon, 1995, Vasopressin stimulates steroid secertion in human adrenal glands: comparison with angiotensin 2 effect, Endocrinology, 136, 1285, 10.1210/en.136.3.1285 Halko, 1995, Serum prolactin levels and disease activity in RA, Arthritis and Rheumatism, 38, S289 Hall, 1994, Abnormal hypothalamic pituitary adrenal axis function in RA, Arthritis and Rheumatism, 37, 1132, 10.1002/art.1780370804 Harbuz, 1993, Changes in hypothalamic corticotrophin releaseing factor and pituitary POMC mRNA during the course of experimental allergic encephalomyelitis, Journal of Neurendocrinology, 45, 127 Hench, 1938, The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrathrosis, 13, 161 Hernanz, 1993, Calcitonin gene related peptide, substance P and VIP in the plasma and synovial fluid of patients with inflammatory joint disease, British Journal of Rheumatology, 32, 31, 10.1093/rheumatology/32.1.31 Hillhouse, 1989, Effect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro, Journal of Endocrinology, 122, 719, 10.1677/joe.0.1220719 Jarvinen, 1994, Twin studies in rheumatic diseases, 24, 19 Jorgensen, 1995, Dysregulation of hypothalamo-pituitary axis in rheumatoid arthritis, Journal of Rheumatology Karalis, 1990, Inflammatory disease suceptible Lewis rats: evidence for central deficiency but peripheral excess of CRH synthesis/secretion, Pediatric Research, 29, 80A Katsikis, 1994, Immunoregulatory role of interleukin 10 in rheumatoid arthritis, Journal of Experimental Medicine, 179, 1517, 10.1084/jem.179.5.1517 Kovacs, 1987, Dexamethasone inhibits corticotropin releasing factor gene expression inthe rat paraventricular nucleus, Neuroendocrinology, 46, 365, 10.1159/000124846 Leijon, 1994, Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells, International Immunology, 6, 339, 10.1093/intimm/6.2.339 Levick, 1990, Hypoxia and acidosis in chronic inflammatory arthritis: Relation to vascular supply and dynamic effusion pressure, Journal of Rheumatology, 17, 579 Mackiewicz, 1992, Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute phase proteins, Journal of Immunology, 146, 2021, 10.4049/jimmunol.149.6.2021 Marguerie, 1990, A pilot study comparing bromocriptine with d-penicillamine in the treatment of rheumatoid arthritis, British Journal of Rheumatology, 29, 3 Masi, 1994, Incidence of rheumatoid arthritis: Do the observed age-sex interaction patterns support a role of androgenic-anabolic (AA) steroid deficiency in its pathogenesis?, British Journal of Rheumatology, 33, 697, 10.1093/rheumatology/33.8.697 Masi, 1995, Integrated hormonal-immunological-vascular (‘H-I-V’ triad) systems interactions in rheumatic diseases, Clinical and Experimental Rheumatology, 13, 203 Mason, 1990, The role of the neuroendocrine system in determining susceptibility to experimental allergic encephalomyelitis in the rat, Immunology, 70, 1 Miossec, 1992, Inhibition of the production of pro-inflammatory cytokines and immunoglobins by IL-4 in an ex-vivo model of rheumatoid synovitis, Arthritis and Rheumatism, 35, 874, 10.1002/art.1780350805 Morita, 1995, Anti-inflammatory properties of interleukin-13 in rheumatoid synovial inflammation, Arthritis and Rheumatism, 38, S353 Neeck, 1990, Adrenal secretion of cortisol in patients with rheumatoid arthritis, Journal of Rheumatology, 17, 24 Nelson, 1993, Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced ameliorization of rheumatoid arthritis, New England Journal of Medicine, 329, 466, 10.1056/NEJM199308123290704 Patchev, 1992, Increased plasma concentrations, hypothalamic content, and in vitro release of arginine-vasopressin in inflammatory disease-prone, hypothalamicCRH-deficient Lewis rats, Endocrinology, 131, 1453, 10.1210/en.131.3.1453 Patchev, 1993, Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats of inflammatory disease, Neuroendocrinology, 58, 106, 10.1159/000126519 Peers, 1995, Endogenous corticosteroids modulate lymphoproliferation and susceptibility to experimental allergic encephalomyelitis in the Brown Norway rat, International Archives of Allergy and Immunology, 106, 20, 10.1159/000236885 Perraudin, 1993, Vasopressin stimulates cortisol secretion from human adrenal tissue through activation of Vi receptors, Journal of Clinical Endocrinology and Metabolism, 76, 1522, 10.1210/jc.76.6.1522 Risdon, 1990, Mechanisms of chemoprevention by dietary DHEA: inhibition of lymphopoiesis, American Journal of Pathology, 136, 759 Rivier, 1995, Blocking of nitric oxide production by blood-borne IL-1 β: role of AVP, prostaglandins and α1-adrenergic receptors, Endocrinology, 136, 3597, 10.1210/en.136.8.3597 Rivier, 1983, Interaction of corticotropin-releasing factor and arginine vasopressin on ACTH secretion in vivo, Endocrinology, 113, 939, 10.1210/endo-113-3-939 Roche, 1988, Nucleated sequence of the gene coding for ovine corticotropin-releasing factor and regulation of its mRNA levels by glucocorticoids, Gene, 71, 421, 10.1016/0378-1119(88)90059-5 Romagnani, 1991, Human Th1 and Th2 subsets: doubt no more, Immunology Today, 12, 256, 10.1016/0167-5699(91)90120-I Rook, 1994, Hormones, peripherally activated prohormones and regulation of the Th1/Th2/balance, Immunology Today, 15, 301, 10.1016/0167-5699(94)90075-2 Rothschild, 1982, Pathogenesis of rheumatoid arthritis: A vascular hypothesis, 12, 11 Saldanha, 1986, Evidence for anti-inflammatory effect of normal circulating plasma cortisol, Clinical and Experimental Rheumatology, 4, 365 Salgame, 1991, Differing lymphokine profile of functional subsets of human CD4 and CD8 T cell clones, Science, 254, 279, 10.1126/science.1681588 Shibahara, 1983, Isolation and sequence analysis of human CRF gene, EMBO Journal, 2, 775, 10.1002/j.1460-2075.1983.tb01499.x Silman, 1992, The genetic epidemiology of rheumatoid arhtritis, Clinical Experimental Rheumatology, 10, 309 Stastry, 1978, Association of B cell alloantigen Drw4 with rheumatoid arthritis, New England Journal of Medicine, 298, 869, 10.1056/NEJM197804202981602 Sternberg, 1989, Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats, 86, 2374 Sternberg, 1989, A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats, 86, 4771 Stevens, 1991, A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium, Arthritis and Rheumatism, 34, 1508, 10.1002/art.1780341206 Suda, 1990, Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus, Endocrinology, 126, 1223, 10.1210/endo-126-2-1223 Sweep, 1991, Activation of the hypothalamus-pituitary-adrenal axis by cytokines, Acta Endocrinology (Copenhagen), 125, 84 Thompson, 1987, Rat corticotropin-releasing hormone gene: sequence and tissue specific expression, Molecular Endocrinology, 1, 363, 10.1210/mend-1-5-363 Tsagarakis, 1989, Morphine directly modulates the release of stimulated CRF-41 from rat hypothalamus in vitro, Endocrinology, 124, 2330, 10.1210/endo-124-5-2330 Tsagarakis, 1988, Acetylcholine and norepinephrine stimulate CRF-41 release from the rat hypothalamus in vitro, Endocrinology, 123, 1962, 10.1210/endo-123-4-1962 Udelsman, 1988, Hormonal responses to surgical stress, 265, 10.1007/978-1-4899-2064-5_21 Vamvakopoulos, 1993, Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphismof the stress response and immune/inflammatory reaction, Journal of Clinical Investigations, 92, 1896, 10.1172/JCI116782 Vamvakopoulos, 1990, Structural analysis of the regulatory region of the human corticotropin releasing hormone gene, FEBS Letter, 267, 1, 10.1016/0014-5793(90)80272-K Van, 1990, Glucocorticoid repression of 3′, 5′ cyclic adenosine monophosphate dependent human corticotropin releasing hormone gene promoter activity in a transfected mouse anterior pituitary cell line, Endocrinology, 127, 1412, 10.1210/endo-127-3-1412 van der Bergh, 1993, β-endorphin stimulates Ia expression on mouse cells by inducing IL-4 secretion by CD4+ T cells, Cell Immunology, 149, 180, 10.1006/cimm.1993.1146 Varani, 1994, The vascular endothelium and acute inflammation, 11.1 Weyand, 1994, Disease mechanisms in rheumatoid arthritis: Gene dosage effect of HLA-DR haplotypes, Journal of Laboratory and Clinical Medicine, 124, 335 Weyand, 1992, The influence of HLA-DRB1 genes on disease severity, Annals of Internal Medicine, 117, 801, 10.7326/0003-4819-117-10-801 Wick, 1993, The role of modulatory factors in the multifaceted pathogenesis of autoimmune thyroiditis, International Reviews of Immunology, 9, 77, 10.3109/08830189209061784 Wilder, 1982, Strain and sex variation in the susceptibility to streptococcal cell wall induced arthritis in rats, Arthritis and Rheumatism, 25, 1064, 10.1002/art.1780250906 Wilder, 1983, The pathogenesis of group A streptococcal cell wall induced polyarthritis in rat, Arthritis and Rheumatism, 26, 442, 10.1002/art.1780261205 Williams, 1994, Autoimmunity in rheumatoid arthritis, 9.1 Wittert, 1990, Arginine vasopressin in Cushings disease, Lancet, 335, 991, 10.1016/0140-6736(90)91063-G Wordsworth, 1990, The immunogenetics of RA, Current Opinions in Rheumatology, 2, 423, 10.1097/00002281-199002030-00002 Wu, 1991, Glucocorticoids suppress the production of IL-4 by human lymphocytes, European Journal of Immunology, 21, 2645, 10.1002/eji.1830211053 Yelamos, 1993, Association of HLA DR4 and DR10 with rheumatoid arthritis in a Spanish population, Arthritis and Rheumatism, 36, 811, 10.1002/art.1780360611 Yssel, 1992, IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood cells, Journal of Immunology, 149, 2378, 10.4049/jimmunol.149.7.2378